18th Dec 2014 15:27
For Immediate Release | 18 December 2014 |
ALLIANCE PHARMA PLC
("Alliance" or the "Company")
Directorate Change
Alliance Pharma plc (AIM: APH), the speciality pharmaceutical company, confirms that, further to the announcement on 30 December 2013, Paul Ranson will retire from his position as Non-Executive Director of the Company on 31 December 2014.
For further information:
Alliance Pharma plc | + 44 (0) 1249 466966 |
John Dawson, Chief Executive | |
Richard Wright, Finance Director | |
www.alliancepharma.co.uk | |
Buchanan | + 44 (0) 20 7466 5000 |
Mark Court / Sophie Cowles / Jane Glover | |
Numis Securities Limited | + 44 (0) 20 7260 1000 |
Nominated Adviser: Michael Meade / Freddie Barnfield | |
Corporate Broking: David Poutney |
Notes to editors:
About Alliance
Alliance, founded in 1998, is an AIM listed speciality pharmaceutical company based in Chippenham, Wiltshire, UK. The Company has a strong track record of acquiring the rights to established niche products and owns or licenses the rights to more than 60 pharmaceutical products and continues to explore opportunities to expand the range.
Alliance joined the AIM market of the London Stock Exchange in December 2003 and trades under the symbol APH.
Related Shares:
Alliance Pharma